Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,622Revenue (TTM) $M186Net Margin (%)-94.0Altman Z-Score3.3
Enterprise Value $M2,402EPS (TTM) $-1.5Operating Margin %-68.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-97.5Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %--Quick Ratio2.9Cash flow > EarningsY
Price/Sales13.85-y EBITDA Growth Rate %--Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-17.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-26.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M119ROIC % (ttm)-28.9Gross Margin Increase y-yY

Gurus Latest Trades with XON

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XONJoel Greenblatt 2016-09-30 Sold Out -0.01%$23.08 - $29.84
($26.68)
$ 23.38-12%Sold Out0
XONGeorge Soros 2016-06-30 Sold Out -0.05%$23.82 - $38
($28.7)
$ 23.38-19%Sold Out0
XONFirst Eagle Investment 2016-06-30 Reduce-0.01%$23.82 - $38
($28.7)
$ 23.38-19%Reduce -7.19%1,102,004
XONJoel Greenblatt 2016-06-30 Add$23.82 - $38
($28.7)
$ 23.38-19%Add 21.64%28,320
XONGeorge Soros 2016-03-31 Buy 0.05%$21.38 - $38.9
($31.64)
$ 23.38-26%New holding57,100
XONJoel Greenblatt 2016-03-31 Reduce-0.01%$21.38 - $38.9
($31.64)
$ 23.38-26%Reduce -59.45%23,282
XONJoel Greenblatt 2015-12-31 Buy 0.02%$29.56 - $42.8
($34.08)
$ 23.38-31%New holding57,418
XONFirst Eagle Investment 2015-12-31 Add0.01%$29.56 - $42.8
($34.08)
$ 23.38-31%Add 17.60%1,187,389
XONT Boone Pickens 2015-09-30 Sold Out -1.08%$29.39 - $68.71
($49.28)
$ 23.38-53%Sold Out0
XONFirst Eagle Investment 2015-09-30 Add0.01%$29.39 - $68.71
($49.28)
$ 23.38-53%Add 15.71%1,009,689
XONFirst Eagle Investment 2015-06-30 Add0.01%$37.33 - $50.71
($42.54)
$ 23.38-45%Add 5.37%872,604
XONT Boone Pickens 2015-03-31 Add0.9%$26.08 - $50.16
($37.59)
$ 23.38-38%Add 75.00%17,500
XONFirst Eagle Investment 2015-03-31 Add$26.08 - $50.16
($37.59)
$ 23.38-38%Add 4.84%828,104
XONT Boone Pickens 2014-12-31 Buy 0.53%$16.61 - $28.02
($23.05)
$ 23.381%New holding10,000
XONDavid Einhorn 2014-12-31 Sold Out -0.05%$16.61 - $28.02
($22.97)
$ 23.382%Sold Out0
XONDavid Einhorn 2014-09-30 Reduce-0.06%$17.86 - $26.59
($21.29)
$ 23.3810%Reduce -47.39%197,278
XONDavid Einhorn 2014-06-30 Reduce-0.39%$15.3 - $25.93
($21.15)
$ 23.3811%Reduce -72.81%375,000
XONFirst Eagle Investment 2014-06-30 Buy 0.04%$15.3 - $25.93
($21.15)
$ 23.3811%New holding661,564
XONDavid Einhorn 2014-03-31 Reduce-0.26%$22.5 - $36.82
($28.82)
$ 23.38-19%Reduce -37.58%1,379,014
XONT Boone Pickens 2013-12-31 Sold Out -0.47%$17.65 - $25.5
($21.05)
$ 23.3811%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XON is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XON: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JCEO, 10% Owner 2016-12-13Buy34,606$28.9-19.1view
LIFFMAN JOEL DSVP, Finance 2016-12-12Buy8,500$28.62-18.31view
Hassan FredDirector 2016-12-01Buy6,900$29.02-19.43view
Nimrodi NirSVP-Corporate Development 2016-08-29Buy4,000$26.12-10.49view
KIRK RANDAL JCEO, 10% Owner 2016-05-13Buy41,830$23.92-2.26view
KIRK RANDAL JCEO, 10% Owner 2015-12-11Buy124,475$29.85-21.68view
KIRK RANDAL JCEO, 10% Owner 2015-12-07Buy237,525$30.69-23.82view
Krishnan Krish SCOO 2015-12-04Sell20,900$35.66-34.44view
Krishnan SumaSVP--Product Development 2015-12-04Sell20,900$35.66-34.44view
KIRK RANDAL JCEO, 10% Owner 2015-01-27Buy555,556$27-13.41view

Press Releases about XON :

Quarterly/Annual Reports about XON:

News about XON:

Articles On GuruFocus.com
Weekly CEO Buys Highlight Dec 19 2016 
CEO of Intrexon Invests in Company Dec 15 2016 
The Emperor Has No Clothes Aug 17 2016 
CEO and Part Owner of JMP Group Invests in Company Jan 20 2016 
Intrexon Corp is expanding his business Jun 25 2015 
Bill Miller Identifies What Could Be The Stock of The Decade Feb 10 2015 
5-Year Lows: American Eagle Outfitters, Intrexon Corp, Mack-Cali Realty Corp, and Weight Watchers In Apr 20 2014 
Daniel Loeb Comments on Intrexon Corporation Jan 22 2014 
Daniel Loeb Lags S&P But Top New Stocks Advance Jan 07 2014 
David Einhorn’s New Stocks – TPX, XON, NVR Nov 14 2013 

More From Other Websites
AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon Jan 19 2017
Intrexon Announces "When-Issued" Trading of AquaBounty Technologies In Connection With Special Stock... Jan 12 2017
INTREXON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 11 2017
ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National... Jan 10 2017
Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation Jan 09 2017
INTREXON CORP Financials Jan 07 2017
INTREXON CORP Financials Jan 05 2017
Fibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic... Jan 05 2017
Oragenics Shareholder Update Jan 04 2017
ZIOPHARM to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 04 2017
Intrexon to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 03 2017
INTREXON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or... Dec 30 2016
Coverage initiated on Intrexon by Northland Capital Dec 29 2016
Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies Dec 29 2016
Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies Dec 29 2016
Weekly CEO Buys Highlight Dec 19 2016
Fibrocell Announces Leadership Changes Dec 19 2016
How Intrexon Corp (XON) Stacks Up Against Its Peers Dec 18 2016
CEO of Intrexon Invests in Company Dec 15 2016
Oragenics Presents Engineering of Improved Lantibiotic Variants at American Society for Microbiology... Dec 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)